×

Extended release of neuregulin for treating heart failure

  • US 10,098,834 B2
  • Filed: 05/22/2014
  • Issued: 10/16/2018
  • Est. Priority Date: 05/22/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating heart failure in a mammal, the method comprising administering subcutaneous extended release of neuregulin into a mammal in an amount of 0.3 μ

  • g/kg/day to 3.0 μ

    g/kg/day, wherein the subcutaneous extended release of neuregulin into a mammal is accomplished through the use of a pump.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×